vs

Side-by-side financial comparison of Digital Brands Group, Inc. (DBGI) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.

TScan Therapeutics, Inc. is the larger business by last-quarter revenue ($2.6M vs $1.6M, roughly 1.6× Digital Brands Group, Inc.). TScan Therapeutics, Inc. runs the higher net margin — -895.1% vs -1283.8%, a 388.7% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs -25.1%). Over the past eight quarters, TScan Therapeutics, Inc.'s revenue compounded faster (-9.7% CAGR vs -33.0%).

Fortune Brands Innovations, Inc. is an American manufacturer of home and security products, headquartered in Deerfield, Illinois. Its portfolio of businesses and brands includes Moen and the House of Rohl; outdoor living and security products from Therma-Tru, Larson, Fiberon, Master Lock and SentrySafe; and MasterBrand Cabinets. Fortune Brands is a Fortune 500 company and part of the S&P 400 Index. As of December 31, 2021, the company reported employing approximately 28,000 associates and pos...

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.

DBGI vs TCRX — Head-to-Head

Bigger by revenue
TCRX
TCRX
1.6× larger
TCRX
$2.6M
$1.6M
DBGI
Growing faster (revenue YoY)
TCRX
TCRX
+311.1% gap
TCRX
286.0%
-25.1%
DBGI
Higher net margin
TCRX
TCRX
388.7% more per $
TCRX
-895.1%
-1283.8%
DBGI
Faster 2-yr revenue CAGR
TCRX
TCRX
Annualised
TCRX
-9.7%
-33.0%
DBGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DBGI
DBGI
TCRX
TCRX
Revenue
$1.6M
$2.6M
Net Profit
$-20.6M
$-23.0M
Gross Margin
-77.1%
Operating Margin
-1385.4%
-929.4%
Net Margin
-1283.8%
-895.1%
Revenue YoY
-25.1%
286.0%
Net Profit YoY
-283.4%
35.8%
EPS (diluted)
$0.73
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBGI
DBGI
TCRX
TCRX
Q4 25
$1.6M
$2.6M
Q3 25
$1.7M
$2.5M
Q2 25
$2.3M
$3.1M
Q1 25
$1.9M
$2.2M
Q4 24
$2.1M
Q3 24
$2.4M
$1.0M
Q2 24
$3.4M
Q1 24
$3.6M
Net Profit
DBGI
DBGI
TCRX
TCRX
Q4 25
$-20.6M
$-23.0M
Q3 25
$-3.5M
$-35.7M
Q2 25
$-2.1M
$-37.0M
Q1 25
$-2.1M
$-34.1M
Q4 24
$-5.4M
Q3 24
$-3.5M
$-29.9M
Q2 24
$-3.5M
Q1 24
$-683.7K
Gross Margin
DBGI
DBGI
TCRX
TCRX
Q4 25
-77.1%
Q3 25
42.7%
Q2 25
31.6%
Q1 25
46.6%
Q4 24
-35.3%
Q3 24
46.0%
Q2 24
45.9%
Q1 24
48.1%
Operating Margin
DBGI
DBGI
TCRX
TCRX
Q4 25
-1385.4%
-929.4%
Q3 25
-201.3%
-1475.6%
Q2 25
-88.2%
-1256.6%
Q1 25
-106.7%
-1669.7%
Q4 24
-230.1%
Q3 24
-112.4%
-3109.8%
Q2 24
-67.8%
Q1 24
-6.3%
Net Margin
DBGI
DBGI
TCRX
TCRX
Q4 25
-1283.8%
-895.1%
Q3 25
-208.7%
-1422.1%
Q2 25
-94.1%
-1201.3%
Q1 25
-111.7%
-1571.9%
Q4 24
-250.7%
Q3 24
-145.1%
-2849.1%
Q2 24
-103.4%
Q1 24
-19.1%
EPS (diluted)
DBGI
DBGI
TCRX
TCRX
Q4 25
$0.73
$-0.18
Q3 25
$-1.18
$-0.28
Q2 25
$-0.81
$-0.28
Q1 25
$-0.92
$-0.26
Q4 24
$132.02
Q3 24
$-81.53
$-0.25
Q2 24
$-104.18
Q1 24
$-23.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBGI
DBGI
TCRX
TCRX
Cash + ST InvestmentsLiquidity on hand
$1.9M
$152.4M
Total DebtLower is stronger
$6.1M
$32.5M
Stockholders' EquityBook value
$8.8M
$123.1M
Total Assets
$44.5M
$228.8M
Debt / EquityLower = less leverage
0.70×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBGI
DBGI
TCRX
TCRX
Q4 25
$1.9M
$152.4M
Q3 25
$6.7M
$184.5M
Q2 25
$542.6K
$218.0M
Q1 25
$2.2M
$251.7M
Q4 24
$164.4K
Q3 24
$289.3K
$271.1M
Q2 24
$92.8K
Q1 24
$11.3K
Total Debt
DBGI
DBGI
TCRX
TCRX
Q4 25
$6.1M
$32.5M
Q3 25
$32.4M
Q2 25
$32.3M
Q1 25
$32.2M
Q4 24
$6.5M
Q3 24
$30.6M
Q2 24
Q1 24
Stockholders' Equity
DBGI
DBGI
TCRX
TCRX
Q4 25
$8.8M
$123.1M
Q3 25
$16.0M
$144.0M
Q2 25
$7.1M
$176.7M
Q1 25
$6.2M
$210.2M
Q4 24
$-1.3M
Q3 24
$19.0K
$229.1M
Q2 24
$2.7M
Q1 24
$3.0M
Total Assets
DBGI
DBGI
TCRX
TCRX
Q4 25
$44.5M
$228.8M
Q3 25
$41.2M
$262.2M
Q2 25
$27.8M
$298.6M
Q1 25
$27.2M
$332.7M
Q4 24
$19.9M
Q3 24
$23.3M
$348.0M
Q2 24
$24.9M
Q1 24
$24.8M
Debt / Equity
DBGI
DBGI
TCRX
TCRX
Q4 25
0.70×
0.26×
Q3 25
0.23×
Q2 25
0.18×
Q1 25
0.15×
Q4 24
Q3 24
0.13×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBGI
DBGI
TCRX
TCRX
Operating Cash FlowLast quarter
$-4.7M
$-32.0M
Free Cash FlowOCF − Capex
$-32.2M
FCF MarginFCF / Revenue
-1253.3%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-139.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBGI
DBGI
TCRX
TCRX
Q4 25
$-4.7M
$-32.0M
Q3 25
$-5.1M
$-32.5M
Q2 25
$-1.6M
$-33.3M
Q1 25
$-4.5M
$-37.6M
Q4 24
$-2.8M
Q3 24
$-541.6K
$-27.9M
Q2 24
$-1.6M
Q1 24
$-1.2M
Free Cash Flow
DBGI
DBGI
TCRX
TCRX
Q4 25
$-32.2M
Q3 25
$-33.9M
Q2 25
$-34.5M
Q1 25
$-39.1M
Q4 24
Q3 24
$-541.6K
$-29.3M
Q2 24
$-1.6M
Q1 24
$-1.3M
FCF Margin
DBGI
DBGI
TCRX
TCRX
Q4 25
-1253.3%
Q3 25
-1349.6%
Q2 25
-1123.1%
Q1 25
-1801.8%
Q4 24
Q3 24
-22.2%
-2792.0%
Q2 24
-47.9%
Q1 24
-35.1%
Capex Intensity
DBGI
DBGI
TCRX
TCRX
Q4 25
6.7%
Q3 25
56.8%
Q2 25
41.6%
Q1 25
70.6%
Q4 24
Q3 24
0.0%
130.6%
Q2 24
0.3%
Q1 24
0.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons